Closing the global cancer divide- performance of breast cancer care services in a middle income developing country

Table 1 Performance measures for evaluating breast cancer care services in Malaysia

#	Performance measure	Source
	Diagnostic services
	Pathology report confirming malignancy	QOPI [8, 9]
	Biomarker information	QOPI [8, 9]
	Treatment services
	Surgery for women under age 70 with Stage I to III breast cancer within 60 days of date of diagnosis	Malaysian guideline [17]
	Adjuvant multi-agent (combination) chemotherapy for women under age 70 with Stage I (T1c) to III ER/PR negative breast cancer within 120 days of date of diagnosis	ASCO-NCCN [10, 11]
	Radiation therapy for women under age 70 with Stage I to III breast cancer who had breast conserving surgery for breast cancer within 1 year (365 days) of date of diagnosis	ASCO-NCCN [10, 11]
	Radiation therapy for women under age 70 who had mastectomy for breast cancer with node + (four or more positive regional lymph nodes) within 1 year (365 days) of date of diagnosis	NAPBC [12]
	Tamoxifen or Aromatase Inhibitor for women greater than age 17 with Stage I (T1c) to III ER or PR positive breast cancer within 1 year (365 days) of date of diagnosis	ASCO-NCCN [10, 11]
	Trastuzumab therapy for women greater than age 17 with Stage I (T1c) to III HER2 positive breast cancer within 1 year (365 days) of date of diagnosis	QOPI [8, 9]

ISSN: 1471-2407